Two Sigma Securities’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-20,300
Closed -$1.34M 2145
2024
Q3
$1.34M Buy
20,300
+9,000
+80% +$654K 0.02% 736
2024
Q2
$1.04M Sell
11,300
-1,200
-10% -$106K 0.01% 1048
2024
Q1
$1.19M Sell
12,500
-22,800
-65% -$1.92M 0.01% 1029
2023
Q4
$2.69M Buy
35,300
+30,300
+606% +$2.11M 0.03% 579
2023
Q3
$346K Buy
5,000
+600
+14% +$48.2K ﹤0.01% 1829
2023
Q2
$415K Sell
4,400
-12,300
-74% -$1.07M 0.01% 1578
2023
Q1
$1.38M Buy
+16,700
New +$1.31M 0.03% 678
2022
Q2
Sell
-3,000
Closed -$353K 2398
2022
Q1
$353K Buy
+3,000
New +$337K 0.01% 1265
2021
Q1
Sell
-7,400
Closed -$675K 1115
2020
Q4
$675K Buy
+7,400
New +$614K 0.02% 553
2020
Q3
Sell
-5,500
Closed -$380K 1393
2020
Q2
$380K Sell
5,500
-2,900
-35% -$206K 0.01% 759
2020
Q1
$528K Sell
8,400
-74,700
-90% -$5.39M 0.01% 603
2019
Q4
$6.46M Buy
83,100
+51,300
+161% +$4.01M 0.04% 327
2019
Q3
$2.33M Sell
31,800
-20,700
-39% -$1.45M 0.02% 541
2019
Q2
$3.23M Buy
52,500
+16,200
+45% +$980K 0.03% 329
2019
Q1
$2.31M Buy
36,300
+26,400
+267% +$1.51M 0.02% 291
2018
Q4
$505K Sell
9,900
-33,900
-77% -$1.72M 0.01% 985
2018
Q3
$2.54M Sell
43,800
-31,800
-42% -$1.56M 0.02% 597
2018
Q2
$3.67M Buy
75,600
+41,400
+121% +$1.93M 0.02% 614
2018
Q1
$1.59M Buy
+34,200
New +$1.49M 0.01% 1006

Other funds holding EW

Two Sigma Securities's EW Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Edwards Lifesciences (EW) in Q1 2026: 4,637 shares worth $371K. The stake represents 0.04% of the portfolio and ranks #628 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in EW as recently as Q3 2025.

Two Sigma Securities first reported a position in EW in Q2 2016 and has held it in 18 quarters since. The position peaked at $3.19M in Q3 2018. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Two Sigma Securities held 4,637 shares of Edwards Lifesciences worth $371K as of Q1 2026.
  • Edwards Lifesciences was a new Two Sigma Securities position in Q1 2026.
  • Edwards Lifesciences made up 0.04% of Two Sigma Securities's portfolio in Q1 2026, its #628 holding.
  • Two Sigma Securities first reported a position in Edwards Lifesciences in Q2 2016 and has held it in 18 quarters since.
  • Two Sigma Securities's Edwards Lifesciences position peaked at $3.19M in Q3 2018.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.